ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,275,000 | +14.0% | 167,756 | -0.3% | 0.27% | +6.8% |
| Q2 2018 | $1,996,000 | -52.5% | 168,187 | -55.0% | 0.25% | -54.7% |
| Q1 2018 | $4,200,000 | +620.4% | 374,017 | +328.4% | 0.55% | +616.9% |
| Q4 2017 | $583,000 | -2.5% | 87,307 | +19.6% | 0.08% | -4.9% |
| Q3 2017 | $598,000 | -30.6% | 72,996 | -62.0% | 0.08% | -34.1% |
| Q2 2017 | $862,000 | +283.1% | 192,045 | +371.0% | 0.12% | +251.4% |
| Q1 2017 | $225,000 | -54.3% | 40,772 | -32.7% | 0.04% | -58.3% |
| Q1 2016 | $492,000 | – | 60,575 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |